HIV Infection and Associated Opportunistic Infections

  • Wolfgang Enzensberger
  • Walter RoyalIII
  • Karl M. Einhäupl
  • Werner Hacke


Neurological involvement is a major problem in HIV patients. More than half of the patients may develop one or more neurological complications. Ten percent of patients will have a problem affecting the nervous system at initial presentation. It is often possible to effectively treat these patients as outpatients; however, it is occasionally necessary to administer care in an intensive care unit (ICU). Often those patients suffer from additional internal complications, e.g. Pneumocystis carinii pneumonia or generalized cytomegalovirus infection and therefore need interdisciplinary intensive care.


Cryptococcus Neoformans Cryptococcal Meningitis Central Nervous System Lymphoma Ancillary Test Central Nervous System Complication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Abos J, Graus F, Miro JM, Mallolas J, Trilla A, Mercader JM (1991) Intracranial tuberculomas in patients with AIDS. AIDS 5: 461–462PubMedCrossRefGoogle Scholar
  2. Baker JL, Kelen GD, Sivertson KT, Quinn TC (1987) Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA 257: 2609–2611PubMedCrossRefGoogle Scholar
  3. Bartlett JG (1992) Recommendations for the medical care of persons with HIV infection. Crit Care Am 1: 44–49Google Scholar
  4. Berger JR, Kaszovitz B, Post JD, Dickinson G (1987) Progressive multifocal leukoencephalitis associated with human immunodeficiency virus infection. Ann Intern Med 107: 78–87PubMedGoogle Scholar
  5. Carne CA, Tedder RS, Smith A, Sutherland S, Elkington SG, Daly HM, Preston FE, Craske J (1985) Acute encephalopathy coincident with seroconversion for antihuman T lymphotropic virus type III. Lancet II: 1206–1208Google Scholar
  6. Centers for Disease Control (1988) CDC update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings. MMWR 37: 377–388Google Scholar
  7. Chuck SL, Sande ME (1989) Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321: 794–799PubMedCrossRefGoogle Scholar
  8. Culver CM, Gert B (1984) Basic ethical concepts in neurologic practice. Semin Neurol 4: 1–8PubMedCrossRefGoogle Scholar
  9. Enzensberger W (1989) Neuromanifestationen bei AIDS. Schwer, StuttgartGoogle Scholar
  10. Enzensberger W, Enzensberger R, Doerr HW, Fischer P-A (1990) HIV-Infektionsrisiko in der Neurologie. Nervenarzt 61: 250251Google Scholar
  11. Enzensberger W (1991) Neuro-AIDS — aktuelle Entwicklungen. Aktuel Neurol 18: 4248CrossRefGoogle Scholar
  12. Fischer P-A, Enzensberger W (1987) Neurological complications in AIDS. J Neurol 234: 269–279PubMedCrossRefGoogle Scholar
  13. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D (1990) Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 4: 519–521PubMedCrossRefGoogle Scholar
  14. Haverkos HW (1987) Assessment of therapy for toxoplasma encephalitis. The TE study group. Am J Med 82: 907–914PubMedCrossRefGoogle Scholar
  15. Levy RM, Bredesen DE, Rosenblum ML (1985) Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 62: 475–495PubMedCrossRefGoogle Scholar
  16. Luft BJ, Remington JS (1987) Toxoplasmic encephalitis. J Infect Dis 157: 1–6CrossRefGoogle Scholar
  17. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66: 407437Google Scholar
  18. Nelson WA, Bernat JL (1989) Decisions to withhold or terminate treatment. Neurol Clin 7: 759–774PubMedGoogle Scholar
  19. Parsons M (1989) The treatment of tuberculous meningitis. Tubercle 70: 8992CrossRefGoogle Scholar
  20. Rosenblum ML, Levy RM, Bredesen DE (1988) Neurosurgical implications of the acquired immunodeficiency syndrome. Clin Neurosurg 34: 419–445PubMedGoogle Scholar
  21. Rosenblum ML, Levy RM, Bredesen DE (eds) (1988) AIDS and the nervous system. Raven, New YorkGoogle Scholar
  22. Snider WD, Simpson DM, Neilson S, Gold JWM, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14: 403–418PubMedCrossRefGoogle Scholar
  23. Sugar AM, Stern JJ, Dupont B (1990) Overview: treatment of cryptococcal meningitis. Rev Infect Dis 12: S338 — S348PubMedCrossRefGoogle Scholar
  24. Wachter RM, Luce JM, Hopewell PC (1992) Critical care of patients with AIDS. JAMA 267: 541–547PubMedCrossRefGoogle Scholar
  25. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 104: 234–240PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • Wolfgang Enzensberger
  • Walter RoyalIII
  • Karl M. Einhäupl
  • Werner Hacke

There are no affiliations available

Personalised recommendations